Primary Immunodeficiency Disorders in children with Non-Cystic Fibrosis Bronchiectasis
- PMID: 32372587
- DOI: 10.23822/EurAnnACI.1764-1489.151
Primary Immunodeficiency Disorders in children with Non-Cystic Fibrosis Bronchiectasis
Abstract
Introduction. Primary immunodeficiency diseases (PID) are common in patients with non-cystic fibrosis bronchiectasis (NCFB). Our objective was to determine ratio/types of PID in NCFB. Methods. Seventy NCFB patients followed up in a two-year period were enrolled. Results. Median age was 14 years (min-max: 6-30). Male/female ratio was 39/31; parental consanguinity, 38.6%. Most patients with NCFB (84.28%) had their first pulmonary infection within the first year of their lives. Patients had their first pulmonary infection at a median age of 6 months (min-max: 0.5-84), were diagnosed with bronchiectasis at about 9 years (114 months, min-max: 2-276). PID, primary ciliary dyskinesia (PCD), bronchiolitis obliterans, rheumatic/autoimmune diseases, severe congenital heart disease and tuberculosis were evaluated as the most common causes of NCFB. About 40% of patients (n=16) had bronchial hyperreactivity (BH) and asthma. Twenty-nine patients (41.4%) had a PID, and nearly all (n=28) had primary antibody deficiency, including patients with combined T and B cell deficiency. PID and non-PID groups did not differ according to gender, parental consanguinity, age at first pneumonia, age of onset of chronic pulmonary symptoms, bronchiectasis, presence of gastroesophageal reflux disease (GERD), BH and asthma (p greater-than 0.05). Admission to immunology clinic was about 3 years later in PID compared with non-PID group (p less-than 0.001). Five patients got molecular diagnosis, X-linked agammaglobulinemia (n=2), LRBA deficiency (n=1), RASGRP1 deficiency (n=1), MHC Class II deficiency (n=1). They were given monthly IVIG and HSCT was performed for three patients. Conclusions. PID accounted for about 40% of NCFB. Early diagnosis/appropriate treatment have impact on clinical course of a PID patient. Thus, follow-up in also immunology clinics should be a routine for patients who experience pneumonia in the first year of their lives and those with NCFB.
Keywords: bronchiectasis; non Cystic Fibrosis Bronchiectasis; primary immunodeficiency; respiratory infections.
Similar articles
-
Primary immunodeficiency-related bronchiectasis in adults: comparison with bronchiectasis of other etiologies in a French reference center.Respir Res. 2019 Dec 4;20(1):275. doi: 10.1186/s12931-019-1242-4. Respir Res. 2019. PMID: 31801528 Free PMC article.
-
A review of the etiology and clinical presentation of non-cystic fibrosis bronchiectasis: A tertiary care experience.Respir Med. 2018 Apr;137:35-39. doi: 10.1016/j.rmed.2018.02.013. Epub 2018 Feb 24. Respir Med. 2018. PMID: 29605210 Review.
-
Does the effect of comprehensive respiratory physiotherapy home-program differ in children with cystic fibrosis and non-cystic fibrosis bronchiectasis?Eur J Pediatr. 2022 Aug;181(8):2961-2970. doi: 10.1007/s00431-022-04509-5. Epub 2022 May 20. Eur J Pediatr. 2022. PMID: 35595860
-
Changing epidemiology of non-cystic fibrosis bronchiectasis.Turk J Pediatr. 2016;58(1):19-26. doi: 10.24953/turkjped.2016.01.003. Turk J Pediatr. 2016. PMID: 27922232
-
Suspecting non-cystic fibrosis bronchiectasis: What the busy primary care clinician needs to know.Int J Clin Pract. 2017 Feb;71(2):e12924. doi: 10.1111/ijcp.12924. Int J Clin Pract. 2017. PMID: 28238229 Free PMC article. Review.
Cited by
-
Antimicrobial Resistance in Common Respiratory Pathogens of Chronic Bronchiectasis Patients: A Literature Review.Antibiotics (Basel). 2021 Mar 20;10(3):326. doi: 10.3390/antibiotics10030326. Antibiotics (Basel). 2021. PMID: 33804631 Free PMC article. Review.
-
Non-Cystic Fibrosis Bronchiectasis in Pediatric Age: A Case Series in a Metropolitan Area of Northern Italy.Children (Basel). 2022 Sep 19;9(9):1420. doi: 10.3390/children9091420. Children (Basel). 2022. PMID: 36138729 Free PMC article.
-
Clinical characteristics and outcome of non-cystic fibrosis bronchiectasis in children: A tertiary care perspective.SAGE Open Med. 2025 Feb 19;13:20503121251320849. doi: 10.1177/20503121251320849. eCollection 2025. SAGE Open Med. 2025. PMID: 39980590 Free PMC article.
-
Diagnostic Barriers in Children with Immunodeficiencies in Central Asia: A Case-Based Discussion.Pediatr Rep. 2021 Aug 7;13(3):483-489. doi: 10.3390/pediatric13030055. Pediatr Rep. 2021. PMID: 34449684 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials